Supporting the development of TTS

We have technologies for producing TTS, where the drug is delivered through the skin to the systemic blood circulation, thereby reducing adverse drug reactions and promoting high efficacy. Our technology achieves high skin permeability while combining secure attachment to the skin and ease of removal. Based on these technologies, we also provide support to customer companies in the development stage. To support the lifecycle management (LCM) strategies, we also provide solutions as developing external preparations for existing drug products.